137
Views
10
CrossRef citations to date
0
Altmetric
Treatment

Oral propranolol for infantile hemangiomas: a prospective study on the role of 48-hour Holter monitoring in additional safety assessment

, , , , &
Pages 554-558 | Received 11 Oct 2016, Accepted 24 Nov 2016, Published online: 11 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lu Yu, Li Wei, Zigang Xu, Bin Zhang, Xiaofeng Han, Yujuan Sun, Yuanxiang Liu, Chen Wang, Lei Qiu, Bingyu Xiu, Rui He, Li Li & Lin Ma. (2022) Safety assessment of propranolol for infantile hemangioma: a study in an Asian population. Expert Review of Clinical Pharmacology 15:2, pages 237-242.
Read now

Articles from other publishers (9)

Katherine B. Püttgen, Leanna M. Hansen, Christine Lauren, Nicole Stefanko, Erin Mathes, Gerilyn M. Olsen, Megha M. Tollefson, Denise Adams, Eulalia Baselga, Sarah Chamlin, Kristen Corey, Flora F. Frascari, Ilona J. Frieden, Eloise R. Galligan, Deepti Gupta, Anita Haggstrom, Kimberly Horii, Christoph P. Hornik, Justyna Klajn, Leonardo Liberman, Anthony Mancini, Diana Mannschreck, Anelah McGinness, Catherine McCuaig, Brandon Newell, Henry Nguyen, Amy Nopper, Tola Oyesanya, Julie Powell, Megan Reynolds, Monica Rios, Dawn H. Siegel, Kendra Ward, Maria C. Garzon, Peter Frommelt & Beth A. Drolet. (2021) Limited utility of repeated vital sign monitoring during initiation of oral propranolol for complicated infantile hemangioma. Journal of the American Academy of Dermatology 85:2, pages 345-352.
Crossref
Floriane Socchi, Michele Bigorre, Marion Normandin, Guillaume Captier, Didier Bessis, Michel Mondain, Catherine Blanchet, Mohamed Akkari, Pascal Amedro & Arthur Gavotto. (2020) Hemangiol in infantile haemangioma: A paediatric post‐marketing surveillance drug study. British Journal of Clinical Pharmacology 87:4, pages 1970-1980.
Crossref
James D. Phillips, Tyler Merrill, J. Reed Gardner, R. Thomas CollinsIIII, Jenika Sanchez, Adam B. Johnson, Brian K. Eble, Larry D. Hartzell, Jay M. Kincannon & Gresham T. Richter. (2021) Clinical Significance of Screening Electrocardiograms for the Administration of Propranolol for Problematic Infantile Hemangiomas. International Journal of Pediatrics 2021, pages 1-5.
Crossref
Gerilyn M. OlsenLeanna M. HansenNicole S. StefankoErin Mathes, Katherine B. Puttgen, Megha M. Tollefson, Christine Lauren, Anthony J. Mancini, Catherine C. McCuaig, Ilona J. Frieden, Denise Adams, Eulalia Baselga, Sarah Chamlin, Deepti Gupta, Peter Frommelt, Maria C. Garzon, Kimberly Horii, Justyna Klajn, Mohit Maheshwari, Brandon Newell, Henry L. Nguyen, Amy Nopper, Julie Powell, Dawn H. SiegelBeth A. Drolet. (2020) Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome. JAMA Dermatology 156:2, pages 186.
Crossref
Xueqing Li, Kun Yang, Hongwen Li & Ran Huo. (2019) Propranolol Treatment for Infantile Hemangiomas: Short-Term Adverse Effects and Follow-Up to Age Two. BioMed Research International 2019, pages 1-9.
Crossref
Ioannis Polymerou, Tiina Ojala, Pipina Bonou, Laura Martelius & Aphrodite Tzifa. (2019) Successful treatment of cardiac haemangiomas with oral propranolol: a case series of two patients. European Heart Journal - Case Reports 3:2.
Crossref
Rachael Hagen, Erica Ghareeb, Omid Jalali & Zachary Zinn. (2018) Infantile hemangiomas. Current Opinion in Pediatrics 30:4, pages 499-504.
Crossref
Francine Blei. (2018) Update April 2018. Lymphatic Research and Biology 16:2, pages 201-230.
Crossref
Zhi Gao, Yi Zhang, Wei Li & Chen Shi. (2018) Effectiveness and safety of polidocanol for the treatment of hemangiomas and vascular malformations: A meta-analysis. Dermatologic Therapy 31:1, pages e12568.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.